image

REPORT SCOPE & OVERVIEW

The Cell Dissociation Market size was estimated USD 311.8 million in 2022 and is expected to reach USD 864.7 million by 2030 at a CAGR of 13.6% during the forecast period of 2023-2030. 

The cell dissociation process is known to use proteolytic enzymes to remove the adhering cell from the surface or substrate. Cell dissociation cushions feature collagenolytic and proteolytic properties that detach cell lines and tissues from the plastic or glass surfaces of the containers, increasing isolation efficacy with high cell practicality.

Cell Dissociation Market Revenue Analysis

Century Therapeutics and Bristol Myers Squibb announced a research collaboration and license agreement for up to four iPSC-derived initiatives for solid tumors and hematologic malignancies in September 2022. Furthermore, launching novel items provides attractive chances within the anticipated time. LevitasBio, for example, in November 2022, Optimized Tissue Dissociation Reagents release. Tissue dissociation kits from the company are specifically built for the LeviCell processes, enabling for end-to-end handling of a wide range of human and model tissue types such as heart, tumor, brain, liver, lung, and kidney.

MARKET DYNAMICS

DRIVERS

  • Rise in recombinant therapeutics sourced from mammalian cells

The share of recombinant medicines in the biopharmaceutical industry has increased significantly. More than 300 recombinant products had been launched as of June 2022, showing a significant transition toward mammalian-based treatments, which will account for over 67% of therapeutics in 2022. Cell culture products, such as cell dissociation, are essential in the development of mammalian-based recombinant therapies, accelerating business growth.

RESTRAIN 

  • Cell-based research is expensive.

Isolation and purification of cell organelles need costly products, and automated/semi-automated benchtop tools are more expensive than older approaches. Despite the tremendous benefits provided by automated instruments, the high costs associated with these instruments may limit product adoption, thereby restraining market growth.

 OPPORTUNITY 

  • Non-enzymatic tissue dissociation advancement

Companies operating in the market are introducing novel and improved items to compete and create more income. To separate cells from primary tissues, most researchers in R&D institutes and biotechnology companies have relied on standard enzymatic dissociation tools. Although these classic enzymatic dissociation products have advantages, such as improved dissociation while conducting research, they can also be harmful and kill living cells. To address this issue and differentiate their product offers, some companies are launching non-enzymatic, non-cytotoxic solutions. Because of this benefit, the demand for non-enzymatic dissociation products is expanding among a variety of end users.

CHALLENGES

  • Dissociated cell culture has some limitations.

The main challenge of dissociated cultures is their low cell count in comparison to immortalized cell lines. This makes doing biochemical studies needing a large starting material volume challenging. Furthermore, most initial cell cultures are not homogenous, which makes cell dissociation investigations difficult. Neuronal cultures are frequently combinations of glia and neurons that respond to distinct neurotransmitters, making it challenging to identify an individual population of cells.

IMPACT OF RUSSIAN UKRAINE WAR

In response to the ongoing war in Ukraine, Danaher Corp. has banned the export of products to Russia, with the exception of products used for diagnosing and treating patients, as well as the production of vaccines and treatments. The Company incurred a $43 million pretax charge in the first quarter of 2022, principally attributable to the impairment of accounts receivable and inventories, as well as accruals for contractual commitments connected to Russian operations.

KEY SEGMENTS

By Product

  • Enzymatic Dissociation

    • Trypsin

    • Collagenase

    • Elastase

    • Papain

    • Hyaluronidase

    • DNase

    • Others

  • Non-enzymatic dissociation

  • Instruments & Accessories

In 2022, Enzymatic Dissociation segment is expected to held the highest market share of 48.0% during the forecast period due to enzymatic dissociation is a technique that uses enzymes to breakdown the cut-up tissue fragments, freeing the cells from the tissue. Several types of enzymes are utilized in the dissociation process, and they can also be used in tandem. Enzymatic dissociations in general give a more effective and efficient approach of isolating mononuclear cells from the spinal cord and brain.

By Type

  • Tissue Dissociation

  • Cell Detachment

In 2022, the Tissue Dissociation segment is expected to dominate the market growth of 56.6% during the forecast period due to Factors such as biopharmaceutical and pharmaceutical firms' increased attention on the development of monoclonal antibodies and therapeutic customisation are expected to boost the expansion of this segment.

By End User

  • Pharmaceutical And Biotechnology Companies

  • Research & Academic Institutes

Cell Dissociation Market Segmentation Analysis

In 2022, Pharmaceutical and Biotechnology Companies segment is expected to dominate the market growth of 71.7% during the forecast period to due to the cell dissociation enzymes are widely used in medications. Collagenase and trypsin are important enzymes in the preservation of solid tissues and adherent cells for culture and research. Furthermore, cell tissue disaggregation and dissociation represent the beginning of a wide range of research End Users, including cancer treatments, cell growth, and vaccine manufacture.

REGIONAL ANALYSES

North America held a significant market share of around 37.3% in 2022 owing to the region's large proportion can be linked to the government's increased investment initiatives, the increased prevalence of chronic diseases like as cancer, as well as the existence of high-quality clinical and laboratory research infrastructure in the region. According to the Globocan study, roughly 2,281,659 new cancer cases were documented in the United States in 2022, with around 712,391 deaths. Thus, the increased frequency of chronic and infectious diseases, combined with a greater emphasis on cell-based treatments, is extending the market's potential prospects.

Asia-Pacific is witness to expand fastest CAGR rate during the forecast period due to the increasing demand for innovative medicines. Increasing government R&D investments and rapid infrastructure development are two other significant drivers driving regional market expansion. Furthermore, some area businesses are receiving financing to investigate treatments for chronic diseases such as cancer. For example, in June 2022, Immuneel Therapeutics received a budget of USD 15 million for developing affordable cell and gene therapy for cancer patients in India.

REGIONAL COVERAGE

North America

  • US

  • Canada

  • Mexico

Europe

  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America

Key Players

The major key players are Merck KGaA, Thermo Fisher Scientific, Danaher Corp., STEMCELL Technologies, Sartorius AG, BD, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd., S2 Genomics, Inc., Agilent Technologies Inc., and Others.

Danaher Corp-Company Financial Analysis

RECENT DEVELOPMENT

In March 2023, Agilent Technologies Inc. has purchased the revolutionary electron capture dissociation (ECD) technology known as the ExD cell, a tiny equipment for mass spectrometers that allows biological researchers to manufacture biotherapeutic chemicals more quickly to treat disease. This is performed by breaking the chemical bonds of complex biomolecules more fully and precisely, allowing for the extraction of more thorough, exact, and detailed structural information from them.  

In 2021, Danaher (Cytiva) collaborated with Diamyd Medical, who chose Cytiva's FlexFactory technology for producing precision medicine type 1 diabetes vaccines.

In 2021, Danaher (Cytiva) partnered with the Government of Telangana (India) to expand the biopharma business in India by opening new labs.

Cell Dissociation Market Report Scope:
Report Attributes Details
Market Size in 2022  US$ 311.8 Million
Market Size by 2030  US$ 864.7 Million
CAGR   CAGR of 13.6% From 2023 to 2030
Base Year 2022
Forecast Period  2023-2030
Historical Data  2019-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Enzymatic Dissociation, Non-enzymatic dissociation, Instruments & Accessories)
• By Type (Tissue Dissociation, Cell Detachment)
• By End User (Pharmaceutical and Biotechnology Companies, Research & Academic Institutes)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Company Profiles Merck KGaA, Thermo Fisher Scientific, Danaher Corp., STEMCELL Technologies, Sartorius AG, BD, Miltenyi Biotec, PAN-Biotech, HiMedia Laboratories, F. Hoffmann-La Roche Ltd., S2 Genomics, Inc., Agilent Technologies Inc.
Key Drivers • Rise in recombinant therapeutics sourced from mammalian cells
Market Challenges • Dissociated cell culture has some limitations.

 

Frequently Asked Questions

Ans: Cell Dissociation Market is anticipated to expand by 13.6% from 2023 to 2030.

Ans: Cell Dissociation Market size was valued at USD 311.8 million in 2022.

Ans:   USD 864.7 million is expected to grow by 2030.

Ans: Huge range of products available to help researchers, pharmaceutical companies, and clinicians in their efforts to study, manipulate, and utilize cells.

Ans: Limitations of Dissociated cell culture.

Table of Contents

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Cell Dissociation Market Segmentation, By Product
8.1 Enzymatic Dissociation
8.1.1 Trypsin
8.1.2 Collagenase
8.1.3 Elastase
8.1.4 Papain
8.1.5 Hyaluronidase
8.1.6 DNase
8.1.7 Others
8.2 Non-enzymatic dissociation
8.3 Instruments & Accessories

9. Cell Dissociation Market Segmentation, By Type
9.1 Tissue Dissociation
9.2 Cell Detachment

10. Cell Dissociation Market Segmentation, By End User
10.1 Pharmaceutical And Biotechnology Companies
10.2 Research & Academic Institutes

11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Cell Dissociation Market by Country
11.2.2 North America Cell Dissociation Market by Product
11.2.3 North America Cell Dissociation Market by Type
11.2.4 North America Cell Dissociation Market by End User
11.2.5 USA
11.2.5.1 USA Cell Dissociation Market by Product
11.2.5.2 USA Cell Dissociation Market by Type
11.2.5.3 USA Cell Dissociation Market by End User
11.2.6 Canada
11.2.6.1 Canada Cell Dissociation Market by Product
11.2.6.2 Canada Cell Dissociation Market by Type
11.2.6.3 Canada Cell Dissociation Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Cell Dissociation Market by Product
11.2.7.2 Mexico Cell Dissociation Market by Type
11.2.7.3 Mexico Cell Dissociation Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Cell Dissociation Market by Country
11.3.1.2 Eastern Europe Cell Dissociation Market by Product
11.3.1.3 Eastern Europe Cell Dissociation Market by Type
11.3.1.4 Eastern Europe Cell Dissociation Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Cell Dissociation Market by Product
11.3.1.5.2 Poland Cell Dissociation Market by Type
11.3.1.5.3 Poland Cell Dissociation Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Cell Dissociation Market by Product
11.3.1.6.2 Romania Cell Dissociation Market by Type
11.3.1.6.4 Romania Cell Dissociation Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Cell Dissociation Market by Product
11.3.1.7.2 Turkey Cell Dissociation Market by Type
11.3.1.7.3 Turkey Cell Dissociation Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Cell Dissociation Market by Product
11.3.1.8.2 Rest of Eastern Europe Cell Dissociation Market by Type
11.3.1.8.3 Rest of Eastern Europe Cell Dissociation Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Cell Dissociation Market by Product
11.3.2.2 Western Europe Cell Dissociation Market by Type
11.3.2.3 Western Europe Cell Dissociation Market by End User
11.3.2.4 Germany
11.3.2.4.1 Germany Cell Dissociation Market by Product
11.3.2.4.2 Germany Cell Dissociation Market by Type
11.3.2.4.3 Germany Cell Dissociation Market by End User
11.3.2.5 France
11.3.2.5.1 France Cell Dissociation Market by Product
11.3.2.5.2 France Cell Dissociation Market by Type
11.3.2.5.3 France Cell Dissociation Market by End User
11.3.2.6 UK
11.3.2.6.1 UK Cell Dissociation Market by Product
11.3.2.6.2 UK Cell Dissociation Market by Type
11.3.2.6.3 UK Cell Dissociation Market by End User
11.3.2.7 Italy
11.3.2.7.1 Italy Cell Dissociation Market by Product
11.3.2.7.2 Italy Cell Dissociation Market by Type
11.3.2.7.3 Italy Cell Dissociation Market by End User
11.3.2.8 Spain
11.3.2.8.1 Spain Cell Dissociation Market by Product
11.3.2.8.2 Spain Cell Dissociation Market by Type
11.3.2.8.3 Spain Cell Dissociation Market by End User
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Cell Dissociation Market by Product
11.3.2.9.2 Netherlands Cell Dissociation Market by Type
11.3.2.9.3 Netherlands Cell Dissociation Market by End User
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Cell Dissociation Market by Product
11.3.2.10.2 Switzerland Cell Dissociation Market by Type
11.3.2.10.3 Switzerland Cell Dissociation Market by End User
11.3.2.11.1 Austria
11.3.2.11.2 Austria Cell Dissociation Market by Product
11.3.2.11.3 Austria Cell Dissociation Market by Type
11.3.2.11.4 Austria Cell Dissociation Market by End User
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Cell Dissociation Market by Product
11.3.2.12.2 Rest of Western Europe Cell Dissociation Market by Type
11.3.2.12.3 Rest of Western Europe Cell Dissociation Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Cell Dissociation Market by Country
11.4.2 Asia-Pacific Cell Dissociation Market by Product
11.4.3 Asia-Pacific Cell Dissociation Market by Type
11.4.4 Asia-Pacific Cell Dissociation Market by End User
11.4.5 China
11.4.5.1 China Cell Dissociation Market by Product
11.4.5.2 China Cell Dissociation Market by End User
11.4.5.3 China Cell Dissociation Market by Type
11.4.6 India
11.4.6.1 India Cell Dissociation Market by Product
11.4.6.2 India Cell Dissociation Market by Type
11.4.6.3 India Cell Dissociation Market by End User
11.4.7 Japan
11.4.7.1 Japan Cell Dissociation Market by Product
11.4.7.2 Japan Cell Dissociation Market by Type
11.4.7.3 Japan Cell Dissociation Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Cell Dissociation Market by Product
11.4.8.2 South Korea Cell Dissociation Market by Type
11.4.8.3 South Korea Cell Dissociation Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Cell Dissociation Market by Product
11.4.9.2 Vietnam Cell Dissociation Market by Type
11.4.9.3 Vietnam Cell Dissociation Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Cell Dissociation Market by Product
11.4.10.2 Singapore Cell Dissociation Market by Type
11.4.10.3 Singapore Cell Dissociation Market by End User
11.4.11 Australia
11.4.11.1 Australia Cell Dissociation Market by Product
11.4.11.2 Australia Cell Dissociation Market by Type
11.4.11.3 Australia Cell Dissociation Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Cell Dissociation Market by Product
11.4.12.2 Rest of Asia-Pacific Cell Dissociation Market by Type
11.4.12.3 Rest of Asia-Pacific Cell Dissociation Market by End User
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Cell Dissociation Market by Country
11.5.1.2 Middle East Cell Dissociation Market by Product
11.5.1.3 Middle East Cell Dissociation Market by Type
11.5.1.4 Middle East Cell Dissociation Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Cell Dissociation Market by Product
11.5.1.5.2 UAE Cell Dissociation Market by Type
11.5.1.5.3 UAE Cell Dissociation Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Cell Dissociation Market by Product
11.5.1.6.2 Egypt Cell Dissociation Market by Type
11.5.1.6.3 Egypt Cell Dissociation Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Cell Dissociation Market by Product
11.5.1.7.2 Saudi Arabia Cell Dissociation Market by Type
11.5.1.7.3 Saudi Arabia Cell Dissociation Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Cell Dissociation Market by Product
11.5.1.8.2 Qatar Cell Dissociation Market by Type
11.5.1.8.3 Qatar Cell Dissociation Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Cell Dissociation Market by Product
11.5.1.9.2 Rest of Middle East Cell Dissociation Market by Type
11.5.1.9.3 Rest of Middle East Cell Dissociation Market by End User
11.5.2 Africa
11.5.2.1 Africa Cell Dissociation Market by Country
11.5.2.2 Africa Cell Dissociation Market by Product
11.5.2.3 Africa Cell Dissociation Market by Type
11.5.2.4 Africa Cell Dissociation Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Cell Dissociation Market by Product
11.5.2.5.2 Nigeria Cell Dissociation Market by Type
11.5.2.5.3 Nigeria Cell Dissociation Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Cell Dissociation Market by Product
11.5.2.6.2 South Africa Cell Dissociation Market by Type
11.5.2.6.3 South Africa Cell Dissociation Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Cell Dissociation Market by Product
11.5.2.7.2 Rest of Africa Cell Dissociation Market by Type
11.5.2.7.3 Rest of Africa Cell Dissociation Market by End User
11.6 Latin America
11.6.1 Latin America Cell Dissociation Market by Country
11.6.2 Latin America Cell Dissociation Market by Product
11.6.3 Latin America Cell Dissociation Market by Type
11.6.4 Latin America Cell Dissociation Market by End User
11.6.5 Brazil
11.6.5.1 Brazil Cell Dissociation Market by Product
11.6.5.2 Brazil Cell Dissociation Market by Type
11.6.5.3 Brazil Cell Dissociation Market by End User
11.6.6 Argentina
11.6.6.1 Argentina Cell Dissociation Market by Product
11.6.6.2 Argentina Cell Dissociation Market by Type
11.6.6.3 Argentina Cell Dissociation Market by End User
11.6.7 Colombia
11.6.7.1 Colombia Cell Dissociation Market by Product
11.6.7.2 Colombia Cell Dissociation Market by Type
11.6.7.3 Colombia Cell Dissociation Market by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Cell Dissociation Market by Product
11.6.8.2 Rest of Latin America Cell Dissociation Market by Type
11.6.8.3 Rest of Latin America Cell Dissociation Market by End User

12. Company profile
12.1 Merck KGaA
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Thermo Fisher Scientific
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Danaher Corp.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 STEMCELL Technologies
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Sartorius AG
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 BD
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Miltenyi Biotec
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 PAN-Biotech
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 HiMedia Laboratories
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 F. Hoffmann-La Roche Ltd.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 S2 Genomics, Inc.
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Product/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
12.12 Agilent Technologies Inc.
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Product/Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
12.13 Others

13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions

14. Use Case and Best Practices

15. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone